AANA Journal Course: Ketamine and Treatment-Resistant Depression

Add to Cart



+ Add to Cart



+ Add to Cart

Class A Credits: 1

Pharmacology Credits: 1

Format: PDF

Course Launch Date: 10/18/19

Course Expires: 10/17/22

Member/Associate: $35.00

Non-Member: $50.00

The purpose of this activity is to identify patients with treatment-resistant depression.  Patients who suffer from treatment-resistant depression will be offered a trial of ketamine therapy.

The American Association of Nurse Anesthetists is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Post-Test Attempt Notice
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:

The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthetists.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthetists has no responsibility or liability for the accuracy or completeness of the content.

  • Discuss the role of ketamine in alleviating treatmentresistant depression.

Albert Arredondo, DNAP, CRNA

Jennifer K. Lent, DNAP, CRNA

Marilyn A. Pugh, PhD